|
1
|
Phase II trial of sorafenib in metastatic thyroid cancer.
|
J Clin Oncol
|
2009
|
3.73
|
|
2
|
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer.
|
J Clin Oncol
|
2010
|
2.96
|
|
3
|
Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival.
|
Cancer
|
2014
|
1.68
|
|
4
|
PET/CT today and tomorrow.
|
J Nucl Med
|
2004
|
1.68
|
|
5
|
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
|
Blood
|
2011
|
1.55
|
|
6
|
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
|
Leuk Lymphoma
|
2012
|
1.54
|
|
7
|
Do girls really experience more anxiety in mathematics?
|
Psychol Sci
|
2013
|
1.37
|
|
8
|
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
|
Clin Cancer Res
|
2008
|
1.19
|
|
9
|
A comprehensive overview of radioguided surgery using gamma detection probe technology.
|
World J Surg Oncol
|
2009
|
1.16
|
|
10
|
Combined use of preoperative 18F FDG-PET imaging and intraoperative gamma probe detection for accurate assessment of tumor recurrence in patients with colorectal cancer.
|
World J Surg Oncol
|
2007
|
1.11
|
|
11
|
Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup.
|
Arch Otolaryngol Head Neck Surg
|
2009
|
1.01
|
|
12
|
Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
|
Laryngoscope
|
2007
|
0.99
|
|
13
|
Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer.
|
Ann Surg Oncol
|
2006
|
0.99
|
|
14
|
Protein oxidation and heme oxygenase-1 induction in porcine white matter following intracerebral infusions of whole blood or plasma.
|
Dev Neurosci
|
2002
|
0.97
|
|
15
|
Multimodality approach of perioperative 18F-FDG PET/CT imaging, intraoperative 18F-FDG handheld gamma probe detection, and intraoperative ultrasound for tumor localization and verification of resection of all sites of hypermetabolic activity in a case of occult recurrent metastatic melanoma.
|
World J Surg Oncol
|
2008
|
0.96
|
|
16
|
Radioimmunoguided surgery (RIGS), PET/CT image-guided surgery, and fluorescence image-guided surgery: past, present, and future.
|
J Surg Oncol
|
2007
|
0.96
|
|
17
|
Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
|
Ann Surg Oncol
|
2013
|
0.96
|
|
18
|
Modulation of sodium/iodide symporter expression in the salivary gland.
|
Thyroid
|
2013
|
0.96
|
|
19
|
Novel perioperative imaging with 18F-FDG PET/CT and intraoperative 18F-FDG detection using a handheld gamma probe in recurrent ovarian cancer.
|
Gynecol Oncol
|
2008
|
0.95
|
|
20
|
Image-guided cancer therapy using PET/CT.
|
Cancer J
|
2004
|
0.95
|
|
21
|
Bringing advanced medical imaging into the operative arena could revolutionize the surgical care of cancer patients.
|
Expert Rev Med Devices
|
2008
|
0.90
|
|
22
|
Multimodal imaging and detection approach to 18F-FDG-directed surgery for patients with known or suspected malignancies: a comprehensive description of the specific methodology utilized in a single-institution cumulative retrospective experience.
|
World J Surg Oncol
|
2011
|
0.89
|
|
23
|
FDG-PET scan in patients with clinically and/or radiologically suspicious colorectal cancer recurrence but normal CEA.
|
World J Surg Oncol
|
2007
|
0.88
|
|
24
|
Detrimental effects of falling on health and well-being in later life: the mediating roles of perceived control and optimism.
|
J Health Psychol
|
2007
|
0.86
|
|
25
|
Combined use of perioperative TSH-stimulated (18)F-FDG PET/CT imaging and gamma probe radioguided surgery to localize and verify resection of iodine scan-negative recurrent thyroid carcinoma.
|
Laryngoscope
|
2008
|
0.84
|
|
26
|
A novel approach to positron emission tomography in lung cancer.
|
Ann Thorac Surg
|
2008
|
0.84
|
|
27
|
124I-HuCC49deltaCH2 for TAG-72 antigen-directed positron emission tomography (PET) imaging of LS174T colon adenocarcinoma tumor implants in xenograft mice: preliminary results.
|
World J Surg Oncol
|
2010
|
0.83
|
|
28
|
Multimodal imaging and detection strategy with 124 I-labeled chimeric monoclonal antibody cG250 for accurate localization and confirmation of extent of disease during laparoscopic and open surgical resection of clear cell renal cell carcinoma.
|
Surg Innov
|
2012
|
0.82
|
|
29
|
Minimally invasive parathyroidectomy: how effective is preoperative sestamibi scanning?
|
Am Surg
|
2003
|
0.81
|
|
30
|
Comprehensive evaluation of occupational radiation exposure to intraoperative and perioperative personnel from 18F-FDG radioguided surgical procedures.
|
Eur J Nucl Med Mol Imaging
|
2008
|
0.81
|
|
31
|
New developments in imaging and functional biomarker technology for the assessment and management of cancer patients.
|
Expert Rev Med Devices
|
2009
|
0.79
|
|
32
|
Ex vivo specimen FDG PET/CT imaging for oncology.
|
Radiology
|
2010
|
0.79
|
|
33
|
18F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and background tissues.
|
BMC Cancer
|
2014
|
0.79
|
|
34
|
Perioperative (18)F-fluorodeoxyglucose-guided imaging using the becquerel as a quantitative measure for optimizing surgical resection in patients with advanced malignancy.
|
Am J Surg
|
2009
|
0.79
|
|
35
|
PET/CT imaging of clear cell renal cell carcinoma with I labeled chimeric antibody.
|
Ther Adv Urol
|
2009
|
0.78
|
|
36
|
Comparison of two threshold detection criteria methodologies for determination of probe positivity for intraoperative in situ identification of presumed abnormal 18F-FDG-avid tissue sites during radioguided oncologic surgery.
|
BMC Cancer
|
2014
|
0.78
|
|
37
|
Intraoperative detection of ¹⁸F-FDG-avid tissue sites using the increased probe counting efficiency of the K-alpha probe design and variance-based statistical analysis with the three-sigma criteria.
|
BMC Cancer
|
2013
|
0.78
|
|
38
|
Use of intraoperative nuclear medicine imaging technology: strategy for improved patient management.
|
Expert Rev Med Devices
|
2013
|
0.77
|
|
39
|
PET-CT for tumor delineation: in regard to Heron et al. (Int J Radiat Oncol Biol Phys 2004;60:1419-1424).
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.75
|
|
40
|
Recognizing the role of surgical oncology and cancer imaging in the multidisciplinary approach to cancer: an important area of future scholarly growth for BMC Cancer.
|
BMC Cancer
|
2013
|
0.75
|
|
41
|
Rebound thymic hyperplasia after pneumonectomy and chemotherapy for primary synovial sarcoma.
|
J Thorac Imaging
|
2008
|
0.75
|
|
42
|
Precise Localization of Occult Gastrointestinal Hemorrhage Using Dynamic SPECT/CT.
|
Clin Nucl Med
|
2016
|
0.75
|
|
43
|
CT, MRI, and 18F-FDG PET/CT in a patient with nested stromal epithelial tumor of the liver.
|
Clin Nucl Med
|
2015
|
0.75
|